256 related articles for article (PubMed ID: 163870)
1. Herpes simplex virus microneutralization: a simplification of the test.
Stalder H; Oxman MN; Herrmann KL
J Infect Dis; 1975 Apr; 131(4):423-30. PubMed ID: 163870
[TBL] [Abstract][Full Text] [Related]
2. Development of an HSV-1 neutralization test with a glycoprotein D specific antibody for measurement of neutralizing antibody titer in human sera.
Luo Y; Xiong D; Li HH; Qiu SP; Lin CL; Chen Q; Huang CH; Yuan Q; Zhang J; Xia NS
Virol J; 2016 Mar; 13():44. PubMed ID: 26987753
[TBL] [Abstract][Full Text] [Related]
3. Measurement of antibodies to herpesvirus types 1 and 2 in human sera by microradioimmunoassay.
Jankowski MA; Petersen EE; Böcker JF
Acta Virol; 1977 Sep; 21(5):405-11. PubMed ID: 22235
[TBL] [Abstract][Full Text] [Related]
4. Neutralizing antibody to herpes simplex virus by a novel neutralization method with peroxidase-labelled complement Clq.
Taguchi F; Kawasaki T; Matsuzaki T; Lee SM
J Virol Methods; 1991 May; 32(2-3):157-62. PubMed ID: 1651947
[TBL] [Abstract][Full Text] [Related]
5. Solid phase radioimmunoassay for typing herpes simplex viral antibodies in human sera.
Forghani B; Schmidt NJ; Lennette EH
J Clin Microbiol; 1975 Nov; 2(5):410-8. PubMed ID: 172526
[TBL] [Abstract][Full Text] [Related]
6. Comparison of an ELISA technique with quantal micro-neutralization test for serotyping of HSV-1 or HSV-2-infected patients.
Fortier B; Deville Chabrolle A; Huraux JM
J Virol Methods; 1982 Sep; 5(1):11-20. PubMed ID: 6292248
[TBL] [Abstract][Full Text] [Related]
7. Type specificity of complement-requiring and immunoglobulin M neutralizing antibody in initial herpes simplex virus infections of humans.
Schmidt NJ; Forghani B; Lennette EH
Infect Immun; 1975 Oct; 12(4):728-32. PubMed ID: 1193713
[TBL] [Abstract][Full Text] [Related]
8. Detection of herpes simplex virus type 2-specific antibody with glycoprotein G.
Lee FK; Coleman RM; Pereira L; Bailey PD; Tatsuno M; Nahmias AJ
J Clin Microbiol; 1985 Oct; 22(4):641-4. PubMed ID: 3001136
[TBL] [Abstract][Full Text] [Related]
9. Salivary neutralizing activity against herpes simplex virus type 1.
Gyselink R; Coles D; Ash RJ; Fritz ME
J Infect Dis; 1978 May; 137(5):583-6. PubMed ID: 207786
[TBL] [Abstract][Full Text] [Related]
10. Differences in humoral immunogenicity between herpes simplex virus types 1 and 2.
Kampe P; Knoblich A; Dietrich M; Falke D
J Gen Virol; 1985 Oct; 66 ( Pt 10)():2215-23. PubMed ID: 2995556
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of herpes simplex virus type 1 (HSV-1) plaque enlargement by neutralizing sera.
Mannini-Palenzona A; Costanzo F; Foà-Tomasi L; Negosanti M; Lanzoni A
Microbiologica; 1989 Jul; 12(3):231-40. PubMed ID: 2476650
[TBL] [Abstract][Full Text] [Related]
12. Occurrence of antibodies against herpes simplex virus thymidine kinase in human sera.
Gronowitz JS; Källander CF
J Med Virol; 1981; 8(3):177-86. PubMed ID: 6276503
[TBL] [Abstract][Full Text] [Related]
13. Neutralizing serum IgM antibodies in infections with Herpes simplex virus hominis.
Doerr HW; Gross G; Schmitz H
Med Microbiol Immunol; 1976 Dec; 162(3-4):183-92. PubMed ID: 187917
[TBL] [Abstract][Full Text] [Related]
14. Higher Throughput Quantification of Neutralizing Antibody to Herpes Simplex Viruses.
Blevins TP; Mitchell MC; Korom M; Wang H; Yu Y; Morrison LA; Belshe RB
PLoS One; 2015; 10(12):e0144738. PubMed ID: 26658766
[TBL] [Abstract][Full Text] [Related]
15. Type-specific antibodies to herpes simplex virus type 2 (HSV-2) glycoprotein G in pregnant women, infants exposed to maternal HSV-2 infection at delivery, and infants with neonatal herpes.
Sullender WM; Yasukawa LL; Schwartz M; Pereira L; Hensleigh PA; Prober CG; Arvin AM
J Infect Dis; 1988 Jan; 157(1):164-71. PubMed ID: 2826604
[TBL] [Abstract][Full Text] [Related]
16. Indirect hemagglutinating antibody response to Herpesvirus hominis types 1 and 2 in immunized laboratory animals and in natural infections of man.
Back AF; Schmidt NJ
Appl Microbiol; 1974 Sep; 28(3):392-9. PubMed ID: 4371513
[TBL] [Abstract][Full Text] [Related]
17. Type specificity of complement-fixing antibody against herpes simplex virus type 2 AG-4 early antigen in patients with asymptomatic infection.
Sherlock CH; Ashley RL; Shurtleff ML; Mack KD; Corey L
J Clin Microbiol; 1986 Dec; 24(6):1093-7. PubMed ID: 3023439
[TBL] [Abstract][Full Text] [Related]
18. Comparison of Western Blot Analysis to microneutralization for the detection of type-specific herpes simplex virus antibodies.
Bernstein DI; Garratty E; Lovett MA; Bryson YJ
J Med Virol; 1985 Mar; 15(3):223-30. PubMed ID: 2984325
[TBL] [Abstract][Full Text] [Related]
19. Primary and secondary herpes simplex uveitis in rabbits.
Oh JO
Surv Ophthalmol; 1976; 21(2):178-84. PubMed ID: 185739
[TBL] [Abstract][Full Text] [Related]
20. Quantitation of antibodies to Herpes simplex virus types 1 and 2 by complement-dependent antibody lysis of infected cells.
McClung H; Seth P; Rawls WE
Am J Epidemiol; 1976 Aug; 104(2):181-91. PubMed ID: 60057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
